Sunday, November 22, 2026·Focal News

Focal News

Independent local reporting across America

Local

Bayer's $7.25 Billion Roundup Settlement Wins Final Approval in Missouri Court

A Missouri judge has given final approval to a nationwide settlement that could cost Bayer up to $7.25 billion, compensating thousands of people who say the weedkiller Roundup caused their non-Hodgkin lymphoma. The deal adds to roughly $10 billion Bayer already paid to resolve earlier Roundup claims, even as the company continues to deny that glyphosate causes cancer.

Bayer's $7.25 Billion Roundup Settlement Wins Final Approval in Missouri Court

A Missouri circuit court judge on Friday granted final approval to a nationwide settlement that could cost Bayer up to $7.25 billion, resolving claims from thousands of people who say the weedkiller Roundup caused their non-Hodgkin lymphoma.

The agreement, approved by Judge Timothy Boyer, covers people who have been diagnosed or will be diagnosed with the blood cancer and who link it to glyphosate, the active ingredient in Roundup. Boyer described the deal as among the largest mass tort personal-injury class action settlements in U.S. history.

Payments under the settlement range from $10,000 to $165,000 per claimant, depending on factors including occupational exposure to glyphosate in farming or other work, the age at which non-Hodgkin lymphoma was diagnosed, and other considerations.

Bayer CEO Bill Anderson called the approval a "decisive milestone" that will help the company manage the risks of pending and future litigation. Christopher Seeger, the attorney representing plaintiffs, said the order delivers guaranteed compensation to people who have waited more than a decade for resolution.

The settlement is separate from an earlier round of agreements in which Bayer committed roughly $10 billion to $11 billion to resolve more than 100,000 Roundup claims. Bayer acquired Roundup and its original manufacturer, Monsanto, in 2018.

The company has consistently denied that its product causes cancer. The Environmental Protection Agency has concluded that it did not identify cancer risks of concern from glyphosate uses, though the agency is reviewing human-health evidence amid pressure from advocates and scientists. The World Health Organization's cancer agency concluded more than a decade ago that glyphosate is probably carcinogenic to humans, and environmental health researchers have continued to raise concerns.

Earlier this year, the U.S. Supreme Court ruled in Bayer's favor, finding the company could be shielded from some state-court lawsuits alleging it failed to warn consumers about glyphosate's cancer risks. The Trump administration backed Bayer in that case and has issued an executive order aimed at promoting domestic production of glyphosate.

Roundup remains the most widely used weedkiller in the world. Bayer removed glyphosate from its U.S. residential products several years ago, but the chemical is still used in agriculture.

The settlement's final approval closes one chapter of a legal fight that has stretched across more than a decade, but it does not end the broader debate over glyphosate's safety or the regulatory questions that surround its continued use.

More from Focal News